Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jéssica Domingos da Silva, Lucio Mendes Cabral & Valéria Pereira de Sousa. (2022) Stability Indicating Methods for Determination of Third Generation Antiepileptic Drugs and Their Related Substances. Critical Reviews in Analytical Chemistry 52:7, pages 1524-1536.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Christopher Gharibo, Peter Magnusson, Frank Breve, Jo Ann LeQuang & Giustino Varrassi. (2022) Pharmacotherapeutic management of trigeminal neuropathic pain: an update. Expert Opinion on Pharmacotherapy 23:10, pages 1155-1164.
Read now
Read now
Laurent Maximilian Willems, Sebastian Bauer, Felix Rosenow & Adam Strzelczyk. (2019) Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus. Expert Opinion on Pharmacotherapy 20:14, pages 1755-1765.
Read now
Read now
Jasmina R. Milovanović, Slobodan M. Janković, Ana Pejčić, Miloš Milosavljević, Valentina Opančina, Vesela Radonjić, Zoran Protrka & Marina Kostić. (2017) Evaluation of brivaracetam: a new drug to treat epilepsy. Expert Opinion on Pharmacotherapy 18:13, pages 1381-1389.
Read now
Read now
Adam Strzelczyk, Karl Martin Klein, Laurent M. Willems, Felix Rosenow & Sebastian Bauer. (2016) Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus. Expert Review of Clinical Pharmacology 9:5, pages 637-645.
Read now
Read now
Xin Tian, Meizhen Yuan, Qingju Zhou & Xuefeng Wang. (2015) The efficacy and safety of brivaracetam at different doses for partial-onset epilepsy: a meta-analysis of placebo-controlled studies. Expert Opinion on Pharmacotherapy 16:12, pages 1755-1767.
Read now
Read now
Andreas Schulze-Bonhage. (2011) Brivaracetam for the treatment of epilepsy. Expert Opinion on Pharmacotherapy 12:12, pages 1959-1966.
Read now
Read now
Articles from other publishers (18)
Peng-Peng Wu, Bi-Rong Cao, Fu-Yun Tian & Zhao-Bing Gao. (2023) Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil. Neuroscience Bulletin.
Crossref
Crossref
Laura Palumbo, Marianna Carinci, Annunziata Guarino, Laila Asth, Silvia Zucchini, Sonia Missiroli, Alessandro Rimessi, Paolo Pinton & Carlotta Giorgi. (2023) The NLRP3 Inflammasome in Neurodegenerative Disorders: Insights from Epileptic Models. Biomedicines 11:10, pages 2825.
Crossref
Crossref
Guo-Li Shen, Yuan-Yuan Tan, Yuan Hu, Zhi-Chao Chen, Wei Du & Ying-Chun Chen. (2023) Asymmetric Construction of Multifunctional γ-Lactams from 1,3-Dienes and α-Ketoamides via Pd(0)-π-Lewis Base Catalysis. Organic Letters 25:36, pages 6649-6653.
Crossref
Crossref
Cheng-Shih Chen, Edmund Cheung So & Sheng-Nan Wu. (2023) Modulating Hyperpolarization-Activated Cation Currents through Small Molecule Perturbations: Magnitude and Gating Control. Biomedicines 11:8, pages 2177.
Crossref
Crossref
Kiran Kumar Aalapati, Amit Singh & Ranjana S.Patnaik. (2022) A Brief Review of Analytical Methods for the Estimation of Brivaracetam in Pharmaceutical Formulation and Biological Matrices. Journal of Advanced Zoology 43:1, pages 89-95.
Crossref
Crossref
Katharina Kneppe & David Czell. (2022) Brivaracetam – eine gute Alternative in der akuten Behandlung der Trigeminusneuralgie. Praxis 111:1, pages 21-25.
Crossref
Crossref
Dafin F. Muresanu, Olivia Verisezan Rosu, Codruta Birle, Livia Popa, Diana Chira, Stefan Strilciuc & Anca Dana Buzoianu. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
4095
4126
.
Babji Palakeeti, K. Vijendar Reddy, K. Vengatajalabathy Gobi, Pothuraju Nageswara Rao & Jugun Prakash Chinta. (2021) Simple and efficient method for the quantification of antiepileptic drugs in human plasma by using magnetic graphene oxide-β-cyclodextrin composite as a sorbent. Future Journal of Pharmaceutical Sciences 7:1.
Crossref
Crossref
Te-Yu Hung, Sheng-Nan Wu & Chin-Wei Huang. (2021) The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability. Biomedicines 9:4, pages 369.
Crossref
Crossref
Dafin F. Muresanu, Olivia Verisezan Rosu, Codruta Birle, Livia Popa, Diana Chira, Stefan Strilciuc & Anca Dana Buzoianu. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
32
.
A. Strzelczyk, I. Steinig, K. M. Klein, L. M. Willems, S. Knake, F. Rosenow & S. Bauer. (2016) Brivaracetam zur Zusatztherapie bei fokalen EpilepsienBrivaracetam for add-on treatment in focal epilepsy. Der Nervenarzt 87:10, pages 1086-1093.
Crossref
Crossref
Isabelle Niespodziany, Véronique Marie André, Nathalie Leclère, Etienne Hanon, Philippe Ghisdal & Christian Wolff. (2014) Brivaracetam Differentially Affects Voltage‐Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons. CNS Neuroscience & Therapeutics 21:3, pages 241-251.
Crossref
Crossref
Detlev Boison. (2013) Adenosine Kinase: Exploitation for Therapeutic Gain. Pharmacological Reviews 65:3, pages 906-943.
Crossref
Crossref
Pooja S. Banerjee & P. K. Sharma. (2011) New antiepileptic agents: structure–activity relationships. Medicinal Chemistry Research 21:7, pages 1491-1508.
Crossref
Crossref
Michel Gillard, Bruno Fuks, Karine Leclercq & Alain Matagne. (2011) Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties. European Journal of Pharmacology 664:1-3, pages 36-44.
Crossref
Crossref
Xiao-ling DUAN & Nong XIAO. (2011) From levetiracetam to brivaracetam: development of antiepileptic drugs. Academic Journal of Second Military Medical University 31:5, pages 550-553.
Crossref
Crossref
Andrei G. Malykh & M. Reza Sadaie. (2010) Piracetam and Piracetam-Like Drugs. Drugs 70:3, pages 287-312.
Crossref
Crossref
C P PanayiotopoulosC P Panayiotopoulos. 2010. A Clinical Guide to Epileptic Syndromes and their Treatment. A Clinical Guide to Epileptic Syndromes and their Treatment
533
563
.